MMP7 and ovarian carcinoma: Zhao et al. (21) have shown that triptolide inhibits the migration and invasion of ovarian cancer cells through suppressing the expression of MMP-7 in vitro, and thus concluded that triptolide can be used as a fine candidate for treatment of ovarian cancer.